Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

32.00
Delayed Data
As of 3:59pm ET
 -0.02 / -0.06%
Today’s Change
10.26
Today|||52-Week Range
32.12
+12.91%
Year-to-Date
Relypsa (RLYP) Stock Downgraded to 'Hold' at Stifel
Aug 22 / TheStreet.com - Paid Partner Content
Why Relypsa's Stock Jumped 72% in July
Aug 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close32.02
Today’s open31.98
Day’s range31.97 - 32.03
Volume2,514,856
Average volume (3 months)3,368,348
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)-80.66%
Earnings growth (this year)-43.29%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales62.18
Price/Book7.27

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.07-0.14%
HALOHalozyme Therapeutic...-0.20-1.94%
CHRSCoherus BioSciences ...-0.32-1.06%
AXONAxovant Sciences Ltd+0.25+1.54%
Data as of 4:01pm ET, 08/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$1.59
Annual revenue (last year)$18.6M
Annual profit (last year)-$178.7M
Net profit margin-963.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Chief Financial Officer &
Senior Vice President
Kristine McClintock Ball
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

Search for Jobs